Abstract:Sinonasal papillomas are benign epithelial tumors of the sinonasal tract that are associated with a synchronous or metachronous sinonasal carcinoma in a subset of cases. Our group recently identified mutually exclusive EGFR mutations and human papillomavirus (HPV) infection in inverted sinonasal papillomas and frequent KRAS mutations in oncocytic sinonasal papillomas. We also demonstrated concordant mutational and HPV infection status in sinonasal papilloma-associated sinonasal carcinomas, confirming a clonal relationship between these tumors. Despite our emerging understanding of the oncogenic mechanisms driving formation of sinonasal papillomas, little is currently known about the molecular mechanisms of malignant progression to sinonasal carcinoma. In the present study, we utilized targeted next-generation DNA sequencing to characterize the molecular landscape of a large cohort of sinonasal papilloma-associated sinonasal carcinomas. As expected, EGFR or KRAS mutations were present in the vast majority of tumors. In addition, highly recurrent TP53 mutations, CDKN2A mutations, and/or CDKN2A copy-number losses were detected; overall, nearly all tumors (n = 28/29; 96.6%) harbored at least one TP53 or CDKN2A alteration. TERT copy-number gains also occurred frequently (27.6%); however, no TERT promoter mutations were identified. Other recurrent molecular alterations included NFE2L2 and PIK3CA mutations and SOX2, CCND1, MYC, FGFR1, and EGFR copy-number gains. Importantly, TP53 mutations and CDKN2A alterations were not detected in matched sinonasal papillomas, suggesting that these molecular events are associated with malignant transformation. Compared to aerodigestive tract squamous cell carcinomas from The Cancer Genome Atlas (TCGA) project, sinonasal papilloma-associated sinonasal carcinomas have a distinct molecular phenotype, including more frequent EGFR, KRAS, and CDKN2A mutations, TERT copy-number gains, and low-risk human papillomavirus (HPV) infection. These findings shed light on the molecular mechanisms of malignant progression of sinonasal papillomas and may have important diagnostic and therapeutic implications for patients with advanced sinonasal cancer.

ErbB1 and ErbB2 Overexpression in Patients with Sinonasal Inverted Papilloma and Inverted Papilloma with Squamous Cell Carcinoma in China

Characteristics of Nasal Inverted Papilloma and Its Malignant Transformation: A Study of Cell Proliferation and Programmed Cell Death

Inability of PET/CT to Identify a Primary Sinonasal Inverted Papilloma with Squamous Cell Carcinoma in a Patient with a Submandibular Lymph Node Metastasis: A Case Report.

EGFR and KRAS Mutations in Chinese Patients with Sinonasal Inverted Papilloma and Oncocytic Papilloma

Expression and Significance of PCNA and Bcl-2 in Sinonasal Inverted Papillomas

Clinical features and hypoxic marker expression of primary sinonasal and laryngeal small-cell neuroendocrine carcinoma: a small case series

Clinical Significance of HMGB1 and Autophagy‐Related Genes in Sinonasal Inverted Papilloma

Overexpression of FoxM1 in Sinonasal Inverted Papilloma and Associated Squamous Cell Carcinoma.

Histopathological Characteristics and Inflammatory Cell Infiltration in Sinonasal Inverted Papilloma

Identification and Potential Value of Candidate Genes in Patients with Sinonasal inverted papilloma

Prevalence of Human Papillomavirus in Sinonasal Squamous Cell Carcinoma with and Without Association of Inverted Papilloma in Eastern China

Evaluation of Correlation of Cell Cycle Proteins and Ki-67 Interaction in Paranasal Sinus Inverted Papilloma Prognosis and Squamous Cell Carcinoma Transformation

Relationship Between Prognosis of Nasal Inverted Papilloma and Human Papillomavirus Types

Roles of human papillomavirus infection and stathmin in the pathogenesis of sinonasal inverted papilloma

Assessment of TP53 and CDKN2A status as predictive markers of malignant transformation of sinonasal inverted papilloma

TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas

[The expression of PTEN and P16 protein in nasal inverted papilloma]

Comprehensive Analysis of Sinonasal Inverted Papilloma Expression Profiles Identifies Long Non-Coding RNA AKTIP as a Potential Biomarker

EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma

Sinonasal Inverted Papilloma-Associated and De Novo Squamous Cell Carcinoma: A Tale of Two Cities or Not

Diagnostic value of serum squamous cell carcinoma antigen and cytokeratin fragment antigen 21-1 for sinonasal inverted papilloma: an exploratory study